top of page

CGS

Cogstate Ltd

Health Care Technology

·

Healthcare

10

comments

3

fund managers

past 90 days

About Cogstate Ltd

Cogstate Ltd. is a global cognitive science company headquartered in Melbourne, Australia. Founded in 1999, the firm provides digital software services to measure cognition across clinical trials, academic research, and healthcare. Its operations are divided into three segments: Clinical Trials, Healthcare, and Administration. The Clinical Trials segment provides solutions for testing drug efficacy and safety, while the Healthcare segment offers tools for detecting cognitive impairment across patient care. By specializing in cognitive assessment, Cogstate supports researchers and clinicians in monitoring brain health and measuring outcomes in clinical and medical environments.

Commentary Volume

10

Comments

3

Fund managers

0

Past 90 days

SOURCE

ACTION

COMMENT PREVIEW

FUND MANAGER

DATE

Loading...

Source: Ipsum Capital Q4 Quarterly Letter  ·  Published 14 March 2025

Loading...

.

​Loading...

Loading...

Loading...

Loading...

Loading...

Source: Ipsum Capital Q4 Quarterly Letter  ·  Published 14 March 2025

Report a problem

Loading...

.

Loading...

Loading...

Loading...

Loading...

14 Mar 2025

ic

Ipsum Capital

"Lorem ipsum dolor sit amet...

Q4 Letter

14 Mar 2025

ic

Dolor Investments

"Lorem ipsum dolor sit amet...

Q4 Letter

🔒 21 more comments from 10 sources

Unlock full access

§ Important Notice

The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.

Commentary

Sector

Healthcare

Market cap

$429M

Fund managers

3 managers

First covered

30 June 2024

Last updated

30 Apr 2026

Company Details

Related Themes

ic

Ipsum Capital

6 comments

ic

Amet Funds

4 comments

ic

Dolor

3 comments

Top Investors Covering MIN

§ Reminder

The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.

Frequently asked questions about Cogstate Ltd (ASX:CGS)

Frequently asked questions

Who is investing in Cogstate Ltd (ASX:CGS)?

Fund managers including Lakehouse Capital, LSN Capital Partners and Underwood Capital have invested in Cogstate Ltd (ASX:CGS).

What is the short interest in Cogstate Ltd (ASX:CGS)?

According to ASIC filings, there is negligible or no short interest in Cogstate Ltd (ASX:CGS).

What does Cogstate Ltd (ASX:CGS) do?

Cogstate Ltd. is a global cognitive science company headquartered in Melbourne, Australia. Founded in 1999, the firm provides digital software services to measure cognition across clinical trials, academic research, and healthcare. Its operations are divided into three segments: Clinical Trials, Healthcare, and Administration. The Clinical Trials segment provides solutions for testing drug efficacy and safety, while the Healthcare segment offers tools for detecting cognitive impairment across patient care. By specializing in cognitive assessment, Cogstate supports researchers and clinicians in monitoring brain health and measuring outcomes in clinical and medical environments.

bottom of page